<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">32604930</PMID><DateRevised><Year>2020</Year><Month>09</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2076-2607</ISSN><JournalIssue CitedMedium="Print"><Volume>8</Volume><Issue>6</Issue><PubDate><Year>2020</Year><Month>Jun</Month><Day>26</Day></PubDate></JournalIssue><Title>Microorganisms</Title><ISOAbbreviation>Microorganisms</ISOAbbreviation></Journal><ArticleTitle>Multiplexed High-Throughput Serological Assay for Human Enteroviruses.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">963</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/microorganisms8060963</ELocationID><Abstract><AbstractText>Immunological assays detecting antibodies against enteroviruses typically use a single enterovirus serotype as antigen. This limits the ability of such assays to detect antibodies against different enterovirus types and to detect possible type-specific variation in antibody responses. We set out to develop a multiplexed assay for simultaneous detection of antibodies against multiple enterovirus and rhinovirus types encompassing all human infecting species. Seven recombinant VP1 proteins from enteroviruses EV-A to EV-D and rhinoviruses RV-A to RV-C species were produced. Using Meso Scale Diagnostics U-PLEX platform we were able to study antibody reactions against these proteins as well as non-structural enterovirus proteins in a single well with 140 human serum samples. Adults had on average 33-fold stronger antibody responses to these antigens (<i>p</i> &lt; 10<sup>-11</sup>) compared to children, but children had less cross-reactivity between different enterovirus types. The results suggest that this new high-throughput assay offers clear benefits in the evaluation of humoral enterovirus immunity in children, giving more exact information than assays that are based on a single enterovirus type as antigen.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Saarinen</LastName><ForeName>Niila V V</ForeName><Initials>NVV</Initials><Identifier Source="ORCID">0000-0001-5029-974X</Identifier><AffiliationInfo><Affiliation>Faculty of Medicine and Health Technology, Tampere University, 33520 Tampere, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lehtonen</LastName><ForeName>Jussi</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Faculty of Medicine and Health Technology, Tampere University, 33520 Tampere, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Veijola</LastName><ForeName>Riitta</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Paediatrics, University of Oulu, 90570 Oulu, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lempainen</LastName><ForeName>Johanna</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Paediatrics, University of Turku, 20520 Turku, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Knip</LastName><ForeName>Mikael</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-0474-0033</Identifier><AffiliationInfo><Affiliation>Pediatric Research Center, Children's Hospital, University of Helsinki and Helsinki University Hospital, 00029 Helsinki, Finland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, 00029 Helsinki, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hy&#xf6;ty</LastName><ForeName>Heikki</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Faculty of Medicine and Health Technology, Tampere University, 33520 Tampere, Finland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Fimlab Laboratories, 33520 Tampere, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Laitinen</LastName><ForeName>Olli H</ForeName><Initials>OH</Initials><Identifier Source="ORCID">0000-0002-3751-9952</Identifier><AffiliationInfo><Affiliation>Faculty of Medicine and Health Technology, Tampere University, 33520 Tampere, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hyt&#xf6;nen</LastName><ForeName>Vesa P</ForeName><Initials>VP</Initials><Identifier Source="ORCID">0000-0002-9357-1480</Identifier><AffiliationInfo><Affiliation>Faculty of Medicine and Health Technology, Tampere University, 33520 Tampere, Finland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Fimlab Laboratories, 33520 Tampere, Finland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>6118</GrantID><Agency>P&#xe4;ivikki ja Sakari Sohlbergin S&#xe4;&#xe4;ti&#xf6;</Agency><Country/></Grant><Grant><GrantID>1843/31/2014</GrantID><Agency>Business Finland</Agency><Country/></Grant><Grant><GrantID>50181744</GrantID><Agency>Pirkanmaan Rahasto</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>06</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Microorganisms</MedlineTA><NlmUniqueID>101625893</NlmUniqueID><ISSNLinking>2076-2607</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Microorganisms. 2020 Sep 17;8(9):E1426. doi: 10.3390/microorganisms8091426</RefSource><PMID Version="1">32957450</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">enterovirus</Keyword><Keyword MajorTopicYN="N">multiplex immunoassay</Keyword><Keyword MajorTopicYN="N">rhinovirus</Keyword></KeywordList><CoiStatement>H.H. and M.K. own stocks Vactech Ltd., which develops vaccines against picornaviruses. H.H. is the chairman of the Vactech board. H.H. and M.K. also serve on the scientific advisory board of Provention Bio Inc., which is developing an enterovirus vaccine. The other authors have no conflict of interest to declare. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>6</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>6</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>6</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>7</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>7</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>7</Month><Day>2</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>6</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32604930</ArticleId><ArticleId IdType="pmc">PMC7355947</ArticleId><ArticleId IdType="doi">10.3390/microorganisms8060963</ArticleId><ArticleId IdType="pii">microorganisms8060963</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ahn J., Joo C.H., Seo I., Kim D., Kim Y.K., Lee H. All CVB serotypes and clinical isolates induce irreversible cytopathic effects in primary cardiomyocytes. J. Med Virol. 2004;75:290&#x2013;294. doi: 10.1002/jmv.20269.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.20269</ArticleId><ArticleId IdType="pubmed">15602738</ArticleId></ArticleIdList></Reference><Reference><Citation>Adedeji A., Okonko I., Adu F. Comparative study of molecular and antigenic characterization for intratypic differentiation (ITD) of poliovirus strains. J. Med. Virol. 2012;84:1975&#x2013;1979. doi: 10.1002/jmv.23408.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.23408</ArticleId><ArticleId IdType="pubmed">23080505</ArticleId></ArticleIdList></Reference><Reference><Citation>Huber S., Ramsingh A.I. Coxsackievirus-Induced Pancreatitis. Viral Immunol. 2004;17:358&#x2013;369. doi: 10.1089/vim.2004.17.358.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/vim.2004.17.358</ArticleId><ArticleId IdType="pubmed">15357902</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding Y., Chen X., Qian B., Wu G., He T., Feng J., Gao C., Wang L., Wang J., Li X., et al. Characterization of the antibody response against EV71 capsid proteins in Chinese individuals by NEIBM-ELISA. Sci. Rep. 2015;5:10636. doi: 10.1038/srep10636.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep10636</ArticleId><ArticleId IdType="pmc">PMC4448526</ArticleId><ArticleId IdType="pubmed">26023863</ArticleId></ArticleIdList></Reference><Reference><Citation>Samuelson A., Forsgren M., Johansson B., Wahren B., S&#xe4;llberg M. Molecular basis for serological cross-reactivity between enteroviruses. Clin. Diagn. Lab. Immunol. 1994;1:336&#x2013;341. doi: 10.1128/CDLI.1.3.336-341.1994.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CDLI.1.3.336-341.1994</ArticleId><ArticleId IdType="pmc">PMC368258</ArticleId><ArticleId IdType="pubmed">7496972</ArticleId></ArticleIdList></Reference><Reference><Citation>Kupila L., Vuorinen T., Vainionp&#xe4;&#xe4; R., Marttila R.J., Kotilainen P. Diagnosis of Enteroviral Meningitis by Use of Polymerase Chain Reaction of Cerebrospinal Fluid, Stool, and Serum Specimens. Clin. Infect. Dis. 2005;40:982&#x2013;987. doi: 10.1086/428581.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/428581</ArticleId><ArticleId IdType="pubmed">15824990</ArticleId></ArticleIdList></Reference><Reference><Citation>Stene L.C., Rewers M. Immunology in the clinic review series; focus on type 1 diabetes and viruses: The enterovirus link to type 1 diabetes: Critical review of human studies. Clin. Exp. Immunol. 2012;168:12&#x2013;23. doi: 10.1111/j.1365-2249.2011.04555.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2249.2011.04555.x</ArticleId><ArticleId IdType="pmc">PMC3390488</ArticleId><ArticleId IdType="pubmed">22385232</ArticleId></ArticleIdList></Reference><Reference><Citation>Freund M.W., Kleinveld G., Krediet T.G., van Loon A.M., A Verboon-Maciolek M. Prognosis for neonates with enterovirus myocarditis. Arch. Dis. Child. Fetal Neonat. Ed. 2010;95:206. doi: 10.1136/adc.2009.165183.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/adc.2009.165183</ArticleId><ArticleId IdType="pubmed">20444813</ArticleId></ArticleIdList></Reference><Reference><Citation>Arbustini E., Porcu E., Bellini O., Grasso M., Pilotto A., Dal B., Morbini P., Diegoli M., Gavazzi A., Specchia G., et al. Enteroviral infection causing fatal myocarditis and subclinical myopathy. Heart. 2000;83:86&#x2013;90. doi: 10.1136/heart.83.1.86.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/heart.83.1.86</ArticleId><ArticleId IdType="pmc">PMC1729289</ArticleId><ArticleId IdType="pubmed">10618342</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim B.-K., Peter A.K., Xiong D., Narezkina A., Yung A., Dalton N.D., Hwang K.-K., Yajima T., Chen J., Knowlton K.U. Inhibition of Coxsackievirus-associated dystrophin cleavage prevents cardiomyopathy. J. Clin. Investig. 2013;123:5146&#x2013;5151. doi: 10.1172/JCI66271.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI66271</ArticleId><ArticleId IdType="pmc">PMC3859391</ArticleId><ArticleId IdType="pubmed">24200690</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo H., Wong B.W. Protein degradation systems in viral myocarditis leading to dilated cardiomyopathy. Cardiovasc. Res. 2009;85:347&#x2013;356. doi: 10.1093/cvr/cvp225.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvp225</ArticleId><ArticleId IdType="pmc">PMC7109953</ArticleId><ArticleId IdType="pubmed">19578074</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoon J.-W., Austin M., Onodera T., Notkins A.L. Virus-Induced Diabetes Mellitus. New Engl. J. Med. 1979;300:1173&#x2013;1179. doi: 10.1056/NEJM197905243002102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM197905243002102</ArticleId><ArticleId IdType="pubmed">219345</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin H.-C., Wang C.-H., Tsai F.-J., Hwang K.-P., Chen W., Lin C.-C., Li T.-C. Enterovirus infection is associated with an increased risk of childhood type 1 diabetes in Taiwan: A nationwide population-based cohort study. Diabetologia. 2014;58:79&#x2013;86. doi: 10.1007/s00125-014-3400-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-014-3400-z</ArticleId><ArticleId IdType="pubmed">25335440</ArticleId></ArticleIdList></Reference><Reference><Citation>Laitinen O.H., Honkanen H., Pakkanen O., Oikarinen S., Hankaniemi M.M., Huhtala H., Ruokoranta T., Lecouturier V., Andr&#xe9; P., Harju R., et al. Coxsackievirus B1 Is Associated With Induction of -Cell Autoimmunity That Portends Type 1 Diabetes. Diabetes. 2013;63:446&#x2013;455. doi: 10.2337/db13-0619.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db13-0619</ArticleId><ArticleId IdType="pubmed">23974921</ArticleId></ArticleIdList></Reference><Reference><Citation>Sioofy-Khojine A.-B., Lehtonen J., Nurminen N., Laitinen O.H., Oikarinen S., Huhtala H., Pakkanen O., Ruokoranta T., Hankaniemi M.M., Toppari J., et al. Coxsackievirus B1 infections are associated with the initiation of insulin-driven autoimmunity that progresses to type 1 diabetes. Diabetologia. 2018;61:1193&#x2013;1202. doi: 10.1007/s00125-018-4561-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-018-4561-y</ArticleId><ArticleId IdType="pubmed">29404673</ArticleId></ArticleIdList></Reference><Reference><Citation>Raimondi S., Lowenfels A.B., Morselli-Labate A.M., Maisonneuve P., Pezzilli R. Pancreatic cancer in chronic pancreatitis; Aetiology, incidence, and early detection. Best Pr. Res. Clin. Gastroenterol. 2010;24:349&#x2013;358. doi: 10.1016/j.bpg.2010.02.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpg.2010.02.007</ArticleId><ArticleId IdType="pubmed">20510834</ArticleId></ArticleIdList></Reference><Reference><Citation>Gern J.E., Busse W.W. Association of Rhinovirus Infections with Asthma. Clin. Microbiol. Rev. 1999;12:9&#x2013;18. doi: 10.1128/CMR.12.1.9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.12.1.9</ArticleId><ArticleId IdType="pmc">PMC88904</ArticleId><ArticleId IdType="pubmed">9880472</ArticleId></ArticleIdList></Reference><Reference><Citation>Samuelson A., Forsgren M., S&#xe4;llberg M. Characterization of the recognition site and diagnostic potential of an enterovirus group-reactive monoclonal antibody. Clin. Diagn. Lab. Immunol. 1995;2:385&#x2013;386. doi: 10.1128/CDLI.2.3.385-386.1995.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CDLI.2.3.385-386.1995</ArticleId><ArticleId IdType="pmc">PMC170165</ArticleId><ArticleId IdType="pubmed">7545081</ArticleId></ArticleIdList></Reference><Reference><Citation>Saarinen N.V.V., Stone V.M., Hankaniemi M.M., Mazur M.A., Vuorinen T., Flodstr&#xf6;m-Tullberg M., Hy&#xf6;ty H., Hyt&#xf6;nen V.P., Laitinen O.H. Antibody Responses against Enterovirus Proteases are Potential Markers for an Acute Infection. Viruses. 2020;12:78. doi: 10.3390/v12010078.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v12010078</ArticleId><ArticleId IdType="pmc">PMC7020046</ArticleId><ArticleId IdType="pubmed">31936473</ArticleId></ArticleIdList></Reference><Reference><Citation>Poelman R., Schuffenecker I., van Leer-Buter C., Josset L., Niesters H.G., Lina B. European surveillance for enterovirus D68 during the emerging North American outbreak in 2014. J. Clin. Virol. 2015;71:1&#x2013;9. doi: 10.1016/j.jcv.2015.07.296.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2015.07.296</ArticleId><ArticleId IdType="pubmed">26364237</ArticleId></ArticleIdList></Reference><Reference><Citation>Edlmayr J., Niespodziana K., Popow-Kraupp T., Krzyzanek V., Focke-Tejkl M., Blaas D., Grote M., Valenta R. Antibodies induced with recombinant VP1 from human rhinovirus exhibit cross-neutralisation. Eur. Respir. J. 2010;37:44&#x2013;52. doi: 10.1183/09031936.00149109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.00149109</ArticleId><ArticleId IdType="pubmed">20530036</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwasaki J., Smith W.-A., Khoo S.-K., Bizzintino J., Zhang G., Cox D.W., Laing I.A., le Souef P., Thomas W.R., Hales B.J. Comparison of rhinovirus antibody titers in children with asthma exacerbations and species-specific rhinovirus infection. J. Allergy Clin. Immunol. 2014;134:25&#x2013;32.e1. doi: 10.1016/j.jaci.2014.03.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2014.03.014</ArticleId><ArticleId IdType="pubmed">24767874</ArticleId></ArticleIdList></Reference><Reference><Citation>Engelmann I., Mordacq C., Gosset P., Tillie-Leblond I., Dewilde A., Thumerelle C., Pouessel G., Deschildre A. Rhinovirus and Asthma: Reinfection, Not Persistence. Am. J. Respir. Crit. Care Med. 2013;188:1165&#x2013;1167. doi: 10.1164/rccm.201303-0585LE.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201303-0585LE</ArticleId><ArticleId IdType="pubmed">24180448</ArticleId></ArticleIdList></Reference><Reference><Citation>Laitinen O.H., Svedin E., Kapell S., Hankaniemi M.M., Larsson P.G., Domsgen E., Stone V.M., M&#xe4;&#xe4;tt&#xe4; J., Hy&#xf6;ty H., Hyt&#xf6;nen V.P., et al. New Coxsackievirus 2Apro and 3Cpro protease antibodies for virus detection and discovery of pathogenic mechanisms. J. Virol. Methods. 2018;255:29&#x2013;37. doi: 10.1016/j.jviromet.2018.02.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jviromet.2018.02.001</ArticleId><ArticleId IdType="pubmed">29425680</ArticleId></ArticleIdList></Reference><Reference><Citation>Laitinen O.H., Airenne K.J., Hyt&#xf6;nen V.P., Peltomaa E., M&#xe4;h&#xf6;nen A.J., Wirth T., Lind M.M., M&#xe4;kel&#xe4; K.A., Toivanen P.I., Schenkwein D., et al. A multipurpose vector system for the screening of libraries in bacteria, insect and mammalian cells and expression in vivo. Nucleic Acids Res. 2005;33:e42. doi: 10.1093/nar/gni042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gni042</ArticleId><ArticleId IdType="pmc">PMC549581</ArticleId><ArticleId IdType="pubmed">15731335</ArticleId></ArticleIdList></Reference><Reference><Citation>Oberbichler E., Wiesauer M., Schl&#xf6;gl E., Stangl J., Faschinger F., Kn&#xf6;r G., Gruber H.J., Hyt&#xf6;nen V.P. Chapter One&#x2014;Competitive binding assay for biotin and biotin derivatives, based on avidin and biotin-4-fluorescein. Methods Enzymol. 2020;633:1&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">32046840</ArticleId></ArticleIdList></Reference><Reference><Citation>Ray S., Steven R.T., Green F.M., H&#xf6;&#xf6;k F., Taskinen B., Hyt&#xf6;nen V.P., Shard A.G. Neutralized Chimeric Avidin Binding at a Reference Biosensor Surface. Langmuir. 2015;31:1921&#x2013;1930. doi: 10.1021/la503213f.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/la503213f</ArticleId><ArticleId IdType="pubmed">25650821</ArticleId></ArticleIdList></Reference><Reference><Citation>N&#xe4;nt&#xf6;-Salonen K., Kupila A., Simell S., Siljander H., Salonsaari T., Hekkala A., Korhonen S., Erkkola R., I Sipil&#xe4; J., Haavisto L., et al. Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies conferring increased risk of disease: A double-blind, randomised controlled trial. Lancet. 2008;372:1746&#x2013;1755. doi: 10.1016/S0140-6736(08)61309-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(08)61309-4</ArticleId><ArticleId IdType="pubmed">18814906</ArticleId></ArticleIdList></Reference><Reference><Citation>Gr&#xf6;nroos M., Parajuli A., Laitinen O.H., Roslund M., Vari H.K., Hy&#xf6;ty H., Puhakka R., Sinkkonen A. Short-term direct contact with soil and plant materials leads to an immediate increase in diversity of skin microbiota. Microbiologiopen. 2018;8:e00645. doi: 10.1002/mbo3.645.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mbo3.645</ArticleId><ArticleId IdType="pmc">PMC6436432</ArticleId><ArticleId IdType="pubmed">29808965</ArticleId></ArticleIdList></Reference><Reference><Citation>Saarinen N.V.V., Laiho J.E., Richardson S.J., Zeissler M., Stone V.M., Marjom&#xe4;ki V.S., Kantoluoto T., Horwitz M.S., Sioofy-Khojine A.-B., Honkimaa A., et al. A novel rat CVB1-VP1 monoclonal antibody 3A6 detects a broad range of enteroviruses. Sci. Rep. 2018;8:33. doi: 10.1038/s41598-017-18495-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-18495-4</ArticleId><ArticleId IdType="pmc">PMC5758616</ArticleId><ArticleId IdType="pubmed">29311608</ArticleId></ArticleIdList></Reference><Reference><Citation>Vandini S., Biagi C., Fischer M., Lanari M. Impact of Rhinovirus Infections in Children. Viruses. 2019;11:521. doi: 10.3390/v11060521.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v11060521</ArticleId><ArticleId IdType="pmc">PMC6632063</ArticleId><ArticleId IdType="pubmed">31195744</ArticleId></ArticleIdList></Reference><Reference><Citation>Woodbury N., Bald E., Geist B., Yang T.-Y. Application of multiplexed pharmacokinetic immunoassay to quantify in vivo drug forms and coadministered biologics. Bioanalysis. 2019;11:2251&#x2013;2268. doi: 10.4155/bio-2019-0147.</Citation><ArticleIdList><ArticleId IdType="doi">10.4155/bio-2019-0147</ArticleId><ArticleId IdType="pubmed">31845605</ArticleId></ArticleIdList></Reference><Reference><Citation>Meso Scale Diagnostics.  [(accessed on 6 August 2019)]; Available online:  https://www.mesoscale.com/en/products_and_services/assay_kits/u-plex_gateway/u-plex_technology.</Citation></Reference><Reference><Citation>Stone V.M., Hankaniemi M.M., Laitinen O.H., Sioofy-Khojine A.B., Lin A., Lozano I.M.D., Mazur M.A., Marjom&#xe4;ki V., Lor&#xe9; K., Hy&#xf6;ty H., et al. A hexavalent Coxsackievirus B vaccine is highly immunogenic and has a strong protective capacity in mice and nonhuman primates. Sci. Adv. 2020;6:eaaz2433. doi: 10.1126/sciadv.aaz2433.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.aaz2433</ArticleId><ArticleId IdType="pmc">PMC7202868</ArticleId><ArticleId IdType="pubmed">32494709</ArticleId></ArticleIdList></Reference><Reference><Citation>Hy&#xf6;ty H., Leon F., Knip M. Developing a vaccine for type 1 diabetes by targeting coxsackievirus B. Expert Rev. Vaccines. 2018;17:1071&#x2013;1083. doi: 10.1080/14760584.2018.1548281.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14760584.2018.1548281</ArticleId><ArticleId IdType="pubmed">30449209</ArticleId></ArticleIdList></Reference><Reference><Citation>Niespodziana K., Napora K., Cabauatan C., Focke-Tejkl M., Keller W., Niederberger V., Tsolia M., Christodoulou I., Papadopoulos N.G., Valenta R. Misdirected antibody responses against an N-terminal epitope on human rhinovirus VP1 as explanation for recurrent RV infections. FASEB J. 2011;26:1001&#x2013;1008. doi: 10.1096/fj.11-193557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.11-193557</ArticleId><ArticleId IdType="pubmed">22121050</ArticleId></ArticleIdList></Reference><Reference><Citation>Francis T. On the Doctrine of Original Antigenic Sin. Proc. Am. Philos. Soc. 1960;104:572&#x2013;578.</Citation></Reference><Reference><Citation>Zhang A., Stacey H.D., Mullarkey C.E., Miller M.S. Original Antigenic Sin: How First Exposure Shapes Lifelong Anti&#x2013;Influenza Virus Immune Responses. J. Immunol. 2019;202:335&#x2013;340. doi: 10.4049/jimmunol.1801149.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1801149</ArticleId><ArticleId IdType="pubmed">30617114</ArticleId></ArticleIdList></Reference><Reference><Citation>Pattison J.R. Editorial: Tests for Coxsackie B Virus-Specific IgM. J. Hyg. 1983;90:327&#x2013;332. doi: 10.1017/S0022172400028965.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0022172400028965</ArticleId><ArticleId IdType="pmc">PMC2134265</ArticleId><ArticleId IdType="pubmed">6306096</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>